James O'Leary
2020 - Fusion Pharmaceuticals
In 2020, James O'Leary earned a total compensation of $2.3M as Chief Medical Officer at Fusion Pharmaceuticals.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $158,212 |
| Option Awards | $1,790,283 |
| Salary | $349,380 |
| Other | $5,048 |
| Total | $2,327,923 |
O'Leary received $1.8M in option awards, accounting for 77% of the total pay in 2020.
O'Leary also received $25K in bonus, $158.2K in non-equity incentive plan, $349.4K in salary and $5K in other compensation.
Rankings
In 2020, James O'Leary's compensation ranked 4,867th out of 13,090 executives tracked by ExecPay. In other words, O'Leary earned more than 62.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,867 out of 13,090 | 63rd |
Division Manufacturing | 1,978 out of 5,624 | 65th |
Major group Chemicals And Allied Products | 783 out of 2,257 | 65th |
Industry group Drugs | 675 out of 1,957 | 66th |
Industry Biological Products, Except Diagnostic Substances | 158 out of 411 | 62nd |
Source: SEC filing on April 27, 2021.
O'Leary's colleagues
We found three more compensation records of executives who worked with James O'Leary at Fusion Pharmaceuticals in 2020.